May & Baker Nigeria PLC
MAYBAKE.LG- Latest Trade
- trading lower4.5NGN
- Change
- -0.07
- % Change
1.53%Negative
- Day Range
- 4.31 - 4.50
- 52-Week Range
- 3.91 - 5.45
As of May 21 2022. Values delayed up to 15 minutes
- Previous Close
- 4.57
- Open
- 4.31
- Volume
- 29,959.00
- 3 Month Average Trading Volume
- 10.19
- Shares Out (Mil)
- 1,725.23
- Market Cap
- 7,435.76
- Forward P/E
- -99,999.99
- Dividend Yield
- 6.96
Key Statistics
2 mean rating - 1 analysts
- P/E Excl. Extra Items (TTM)
- 7.46
- Price To Sales (TTM)
- 0.59
- Price To Book (Quarterly)
- 1.00
- Price To Cash Flow (Per Share TTM)
- 4.49
- Total Debt/Total Equity (Quarterly)
- 80.01
- Long Term Debt/Equity (Quarterly)
- 37.53
- Return On Investment (TTM)
- 8.92
- Return On Equity (TTM)
- 6.08
2021 (millions USD)
About May & Baker Nigeria PLC
Company Information
May & Baker Nigeria Plc is a Nigeria-based company, which is involved in the manufacture, sale and distribution of human pharmaceuticals, human vaccines and consumer products. The Company's operating segments include Pharmaceuticals, Beverage and Foods. Its Pharmaceuticals segment is involved in the production and sale of human pharmaceuticals and human vaccines. Its Beverage segment is involved in the production of beverage drinks, including bottled water. Its Foods segment is involved in the production of package foods, including noodles. The Company offers pharmaceutical products for anti-diabetics, anti-hypertensive, anti-infectives, anti-malaria, analgesic, cough and cold, multivitamin and anxiolytics. Its anti-diabetic's products are sold under Diatab and Diamet brands. Its anti-hypertensive products are sold under Cardovasc Retard and Ramitace brands. Its food products are sold under the Mimee brand. Its beverages sector is engaged in the bottling of Lily brand of table water.
Address
3/5 Sapara Street Industrial Estate, P M B 21049, LagosIKEJA,
null
Nigeria
Industry
Biotechnology & Drugs
Executive Leadership
- Daisy Ehanire Danjuma
- Non-Executive Chairman
- Ayodeji S. Aboderin
- Executive Director, Finance
- Yetunde Adigun
- Head, Pharma Plant Operations
- Patrick O. Ajah
- Managing Director, Executive Director
- Chukuka S. Chukutem
- Executive Director, Pharma Sales & Marketing
- Valentine C. Okelu
- Executive Director, Foods Division
- Gladys N. Umoh
- Head, Human Capital Development
- Edudie Abebe
- Non-Executive Director
- Adebayo Adetunji Adeleke
- Non-Executive Director
- Ishaya Dankaro
- Non-Executive Director
- Gloria Ijeoma Odumodu
- Non-Executive Director
- Samuel Maduka Onyishi
- Non-Executive Director
Markets Performance
Official Data PartnerCommodities
| Future | Last | % Change |
|---|---|---|
| Gold | 1,836.30 | 0.27%Negative |
| Copper | 772.55 | 0.46%Positive |
| Brent Crude Oil | 112.55 | -- |
| CBOT Soybeans | 1,705.75 | 0.90%Positive |
Stocks
| Index | Last | % Change |
|---|---|---|
| S&P 500 | 3,901.36 | 0.01%Positive |
| Euro STOXX 50 | 3,657.03 | 0.45%Positive |
| FTSE 100 | 7,389.98 | 1.19%Positive |
| Nikkei 225 | 26,739.03 | 1.27%Positive |
Source: Refinitiv, an LSEG business - data delayed by at least 15 minutes